SEC Form 4 · accession 0000899243-19-000799
MyoKardia Inc · MYOK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anastasios Gianakakos
Officer — President and CEO · Director
Period of report
Jan 4, 2019
Accepted (ET)
Jan 8, 2019 · 7:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001552451
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 4, 2019 | P | 900 | $39.835 | A | 86,873 | I | By Reporting Person's Trust 2 |
| Common Stock | Jan 4, 2019 | P | 1,600 | $39.8722 | A | 88,473 | I | By Reporting Person's Trust 2 |
| Common Stock | holding | — | — | — | 79,737 | D | ||
| Common Stock | holding | — | — | — | 500,000 | I | By Reporting Person's Trust 3 | |
| Common Stock | holding | — | — | — | 12,200 | I | By Trust 1 | |
| Common Stock | holding | — | — | — | 12,200 | I | By Trust 2 | |
| Common Stock | holding | — | — | — | 12,200 | I | By Trust 3 |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were acquired through an open market purchase.